Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederclinicaltrials.gov
ClinicalTrials.gov: Tirzepatide OR Mounjaro OR LY3298176 OR Retatrutide OR LY3437943 OR LY3502970 OR orforglipron OR Mazdutide OR LY3305677 OR IBI362 OR semaglutide OR CagriSema OR Amycretin OR XW004 OR XW014 OR XW010 OR XW003 OR XW013 OR XW015 OR AMG133
Get the latest updates from ClinicalTrials.gov: Tirzepatide OR Mounjaro OR LY3298176 OR Retatrutide OR LY3437943 OR LY3502970 OR orforglipron OR Mazdutide OR LY3305677 OR IBI362 OR semaglutide OR CagriSema OR Amycretin OR XW004 OR XW014 OR XW010 OR XW003 OR XW013 OR XW015 OR AMG133 directly as they happen.
Follow now < 10 followers
Latest posts
Last updated about 12 hours ago
Does Personality Predict Patient Adherence, Health Behaviors, and Weight Loss Outcomes During the Latino Crossover Semaglutide Study (LCSS)? (Story-LCSS Project)
about 16 hours ago
Conditions: Obesity; Body Weight Changes Interventions: Behavioral: Voice data Sponsors: Loma Linda...
A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia
about 16 hours ago
Conditions: Endometrioid Endometrial Adenocarcinoma Interventions: Drug: Glucagon-like peptide 1 receptor agonist Sponsors...
Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
about 16 hours ago
Conditions: Obesity Interventions: Drug: KAI-9531; Drug: Semaglutide; Drug: Placebo Sponsors: Kailera Recruiting
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
about 16 hours ago
Conditions: Pancreatic Cancer; Colorectal Cancer; Hepatocellular Carcinoma Interventions: Drug: GLP1-RA (semaglutide) Sponsors...
GLP-1 Therapy After Bariatric Surgery in Chinese Patients With Obesity
about 16 hours ago
Conditions: Obesity Interventions: Combination Product: LSG-Semaglutide group; Combination Product: LSG-Mazdutide group; Combination...
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both
about 21 hours ago
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: Cagrilintide; Drug: Semaglutide; Drug: Tirzepatide...
A Phase 1, Parallel, Single-Dose, Open-Label, Single-Period Study of LY3502970 in Participants With Normal Renal Function and Participants With Renal Impairment.
about 21 hours ago
Conditions: Renal Insufficiency; Healthy Interventions: Drug: LY3502970 Sponsors: Eli Lilly and Company...
New Triple Combination Therapy in Newly Diagnosed Type 2 Diabetes
about 21 hours ago
Conditions: Diabetes Mellitus Interventions: Drug: Group A (triple combination intensive therapy group)...
Tirzepatide vs Semaglutide in Individuals at Cardiovascular Risk But Without Diabetes.
about 21 hours ago
Conditions: Obesity; Overweight Interventions: Drug: Tirzepatide; Drug: Semaglutide Sponsors: Brigham and Women's...
Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Risk
about 21 hours ago
Conditions: Type 2 Diabetes Mellitus; Obesity; Overweight Interventions: Drug: Semaglutide; Drug: Dulaglutide...
A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight
about 21 hours ago
Conditions: Obesity; Overweight Interventions: Drug: Retatrutide Sponsors: Eli Lilly and Company Active...
A Study to Evaluate the Safety of Exposure to Wegovy During Pregnancy
about 21 hours ago
Conditions: Pregnancy; Obesity; Overweight Interventions: Other: No Intervention Sponsors: Novo Nordisk A/S...